Clinical trials
Platelets clinical trials
Below are recruiting platelets clinical trials, each written for real people, not researchers. We’re tracking 236 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05667805RecruitingPhase 4
Testing blood clotting in people with liver cirrhosis
This Phase 4 study looks at how clotting measurements relate to bleeding risk in people with liver cirrhosis who need a planned liver procedure. The study may help doctors understand what coagulation results mean when doing these procedures safely.
ViennaAges 18 years+ - NCT05711485Recruiting
Test whole-blood transfusion plan for severe malaria in young children
This trial studies a platelet-focused strategy for giving whole blood to children under 5 with severe malaria. It aims to see whether this approach can improve care while keeping children safe.
Baltimore, MarylandAges 6 months–4.9 years - NCT05713734Recruiting
Study of unexplained bleeding blood tests in adults
This Swiss study looks at people with unexplained bleeding by using a standardized bleeding score and taking a blood sample. It may help researchers better understand possible bleeding causes even when the reason isn’t clear yet.
BellinzonaAges 16–65 - NCT05732701Recruiting
Personalized blood thinner plan after stent placement
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
Banja LukaAges 18 years+ - NCT05885932Recruiting
Stent treatment versus medicines for blocked neck artery
This study compares a drug-coated stent placed in a neck (vertebral) artery versus best medical treatment with medicines and risk-factor control. It aims to reduce problems caused by a badly narrowed artery after recent stroke-like symptoms.
BeijingAges 18 years+ - NCT05985447Recruiting
Menopause and blood cell function study
This study looks at how menopause affects blood cells and platelets in people with heart or lung conditions. It may help understand why risks change after menopause.
DüsseldorfAges 18 years+ - NCT06090669RecruitingPhase 1
Trial of imatinib for people with RUNX1 deficiency
This trial tests if imatinib can help people with a genetic condition called RUNX1 deficiency, which causes bleeding problems. It aims to increase the activity of the RUNX1 gene to improve blood clotting.
Bethesda, MarylandAges 18–120 - NCT06261658Recruiting
Using your own blood to improve ovary tissue transplant
This study tests whether using a special mix made from your own blood (called platelet-rich plasma) can improve the success of putting frozen ovarian tissue back into your body. This might help restore your fertility and hormone function after cancer treatment or other conditions.
Bologna, BOAges Any age - NCT06275399Recruiting
Study of plaque and platelets in narrowed heart arteries
This study looks at how plaque buildup and blood platelets interact in partially blocked heart arteries. It might help find better ways to treat people with chronic coronary syndrome.
Warsaw, Masovian VoivodeshipAges 18 years+ - NCT06442319Recruiting
PRP after ACL reconstruction
This trial tests if injecting platelet-rich plasma (a concentration of your own blood platelets) after ACL reconstruction helps with healing and reduces pain. It's for people who recently had ACL surgery and want to try an extra treatment to improve recovery.
TorunAges 18–45 - NCT06472323Recruiting
Pulsed radiofrequency with platelet-rich plasma for trigeminal neuralgia
This trial tests a treatment that combines pulsed radiofrequency and platelet-rich plasma to see if it works better for trigeminal neuralgia pain that hasn't been helped by standard medicines like carbamazepine.
Beijing, Beijing MunicipalityAges 18–75 - NCT06478537RecruitingPhase 2
Hetrombopag for Immune Tolerance in ITP After Platelet Recovery
This study tests whether a drug called hetrombopag can help your immune system stop attacking your platelets, so your platelet count stays up even after stopping the drug. It's for people with ITP who responded well to hetrombopag but want to see if they can stay in remission without it.
Beijing, Beijing MunicipalityAges 18–50 - NCT06535568Recruiting
Comparing one vs two blood thinners after heart artery balloon treatment
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
Milan, MIAges Any age - NCT06539702Recruiting
Blood tests and BRAF for thyroid nodules
This trial studies whether routine blood counts and a BRAF genetic test can help predict cancer in thyroid nodules that were found to be suspicious (Bethesda 3 category) before surgery. The goal is to better understand which nodules are cancerous.
IstanbulAges 18–75 - NCT06593041Recruiting
Platelets in lupus and other autoimmune diseases
This study looks at how platelets (small blood cells that help with clotting) might play a role in autoimmune diseases like lupus. By understanding this, researchers hope to find new ways to treat these conditions.
Strasbourg, FranceAges 18–70 - NCT03937661RecruitingPhase 2/Phase 3
Platelet-rich plasma injected into ovaries for poor egg responders
This trial studies whether an injection of your own “platelet-rich” plasma into the ovaries can improve egg production in people who respond poorly to fertility treatment. It targets women with low egg reserve and tries to see if this approach helps them get better results from stimulation.
AthensAges 35–47 - NCT06657781Recruiting
Platelet function study in patients with sepsis
This study looks at how platelets (small cells that help blood clot) behave in people with severe infections (sepsis). It explores a specific part of the immune system (inflammasome) linked to platelet activation, which may help develop better treatments for serious infections.
Les Abymes, GuadeloupeAges 18 years+ - NCT06661382RecruitingPhase 1/Phase 2
Cord blood plasma vs placebo for vulvar lichen sclerosus
This study tests whether a shot of concentrated healing cells from umbilical cord blood (called platelet-rich plasma) can help treat vulvar lichen sclerosus better than a placebo shot. It aims to find a new, safe option for women who are not helped by standard treatments.
Milan, MilanAges 18–80 - NCT06694168Recruiting
Gum surgery to repair bone loss, with or without your own healing proteins
This trial tests a gum surgery technique that preserves more of your gum tissue, with or without a special protein-rich material made from your own blood (L-PRF), to repair bone loss from gum disease.
Santiago, San BernardoAges 18 years+ - NCT06717295Recruiting
Blood test to find cancer early and track treatment
This study uses a blood test that looks at your platelets and immune cells to find common cancers early, and for certain cancers, to monitor how well treatment is working.
RosarioAges 40–75 - NCT06727669Recruiting
Long-term study of blood clotting and bleeding disorders
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
Beijing, Beijing MunicipalityAges Any age - NCT06747000Recruiting
Study of fats in blood and platelets
This study looks at how fats (lipids) in your blood affect blood cells called platelets, which help with clotting. It includes both healthy people and those with high cholesterol or other fat issues.
East Providence, Rhode IslandAges 18–69 - NCT06757764RecruitingPhase 4
Stroke from artery narrowing: testing combination of anti-platelet drugs
This trial tests whether a combination of two or three anti-platelet medicines (like aspirin, clopidogrel, or cilostazol) is safe and works better than one alone for people who had a stroke from a narrowed artery. The goal is to prevent another stroke.
Seoul, Songpa-guAges 20 years+ - NCT06782035Recruiting
Effect of dressings on donor site comfort after gum graft surgery
This trial tests whether special dressings applied to the area where a gum graft is taken from can improve patient comfort and quality of life after surgery.
IzmirAges 18–85
Hear when a new Platelets trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for platelets?
- Yes. Clin2 currently lists 236 recruiting platelets studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a platelets trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a platelets trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.